BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8414500)

  • 1. Rb may act as a transcriptional co-activator in undifferentiated F9 cells.
    Bocco JL; Reimund B; Chatton B; Kedinger C
    Oncogene; 1993 Nov; 8(11):2977-86. PubMed ID: 8414500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
    Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
    Kirch HC; Pützer B; Schwabe G; Gnauck HK; Schulte Holthausen H
    Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new component of the transcription factor DRTF1/E2F.
    Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
    Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site.
    Ouellette MM; Chen J; Wright WE; Shay JW
    Oncogene; 1992 Jun; 7(6):1075-81. PubMed ID: 1534398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoblastoma protein recruits histone deacetylase to repress transcription.
    Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
    Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.
    Bandara LR; La Thangue NB
    Nature; 1991 Jun; 351(6326):494-7. PubMed ID: 1710781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an E2F-p130 complex formed during growth arrest.
    Corbeil HB; Branton PE
    Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
    Batsché E; Lipp M; Cremisi C
    Oncogene; 1994 Aug; 9(8):2235-43. PubMed ID: 8036009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A; Espanel X; Brun G
    Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.
    Swaminathan S; Thimmapaya B
    J Mol Biol; 1996 May; 258(5):736-46. PubMed ID: 8637006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
    Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S; Nath N; Adlam M; Chellappan S
    Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.